Amylin forges $1B weight-loss pact with Takeda
FierceBiotech
There's a new entry in the closely-watched race to win approval for a blockbuster new weight loss drug. Amylin Pharmaceuticals announced this morning that
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss DrugsXconomy
Takeda Agrees to Buy Rights to Amylin's Obesity DrugsBloomberg

all 114 news articles »